Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sonoma Pharmaceuticals (SNOA) Debt Ratio (2016 - 2025)

Sonoma Pharmaceuticals has reported Debt Ratio over the past 15 years, most recently at 0.0 for Q3 2025.

  • For Q3 2025, Debt Ratio fell 32.55% year-over-year to 0.0; the TTM value through Sep 2025 reached 0.0, down 32.55%, while the annual FY2025 figure was 0.02, 26.68% down from the prior year.
  • Debt Ratio for Q3 2025 was 0.0 at Sonoma Pharmaceuticals, down from 0.01 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.13 in Q1 2021 and troughed at 0.0 in Q4 2022.
  • A 5-year average of 0.02 and a median of 0.02 in 2025 define the central range for Debt Ratio.
  • On a YoY basis, Debt Ratio climbed as much as 284.99% in 2021 and fell as far as 86.6% in 2021.
  • Year by year, Debt Ratio stood at 0.01 in 2021, then plummeted by 89.27% to 0.0 in 2022, then surged by 179.49% to 0.0 in 2023, then skyrocketed by 99.07% to 0.01 in 2024, then tumbled by 32.55% to 0.0 in 2025.
  • Business Quant data shows Debt Ratio for SNOA at 0.0 in Q3 2025, 0.01 in Q2 2025, and 0.02 in Q1 2025.